Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aduro BioTech Inc. (ADRO)

2.71   0.01 (0.37%) 01-22 16:00
Open: 2.71 Pre. Close: 2.7
High: 2.83 Low: 2.6201
Volume: 458,985 Market Cap: 215M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.833 - 2.846 2.846 - 2.858
Low: 2.589 - 2.604 2.604 - 2.617
Close: 2.687 - 2.711 2.711 - 2.731

Technical analysis

as of: 2019-01-22 4:28:41 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. It is relatively safe to short or sell now, downward move is expected.
Target: Six months: 3.42     One year: 3.84
Support: Support1: 2.34    Support2: 1.95
Resistance: Resistance1: 2.93    Resistance2: 3.29
Pivot: 2.84
Moving Average: MA(5): 2.79     MA(20): 2.77
MA(100): 4.46     MA(250): 6.09
MACD: MACD(12,26): -0.05     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 35.62     %D(3): 44.51
RSI: RSI(14): 44.69
52-week: High: 9.93  Low: 2.34  Change(%): -64.8
Average Vol(K): 3-Month: 103223  10-Days: 59870

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ADRO has closed above bottom band by 21.0%. Bollinger Bands are 74.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ADRO's normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-01-11T13:22:42-05:00
Aduro Biotech (ADRO) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 79.40
Shares Float (M) 77.90
% Held by Insiders
% Held by Institutions 70.20
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.230
EPS Est. Current Year -1.350
EPS Est. Next Year -1.270
EPS Est. Next Quarter -0.380
Forward EPS -1.179
Book Value (p.s.) 1.450
PEG Ratio 2.32
Profit Margin
Operating Margin -637.16
Return on Assets (ttm) -23.0
Return on Equity (ttm) -46.3
Qtrly Rev. Growth -19.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -91.96
Levered Free Cash Flow (M) -52.18

Stock Valuations

P/E -2.20
P/E Growth Ratio
P/BV 1.87
P/S 1024638080.00
P/CF -2.34

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.